D70.1

Billable

Agranulocytosis secondary to cancer chemotherapy

D70.1 is the ICD-10-CM code for Agranulocytosis secondary to cancer chemotherapy. It is a billable, specific code valid for reimbursement.

Status
Billable
Chapter
D50-D89
Parent
D70
Edition
FY2026

D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Use additional code

  • code for adverse effect, if applicable, to identify drug (T45.1X5)

Notes

  • underlying neoplasm

Frequently asked questions

What is ICD-10 code D70.1?
D70.1 is the ICD-10-CM code for "Agranulocytosis secondary to cancer chemotherapy". It falls under D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.
Is D70.1 a billable code?
Yes — D70.1 is a billable, specific ICD-10-CM code valid for reimbursement.

Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.

Look up another ICD-10 code or condition

Powered by Eleplan

Free ICD-10 lookup is just the start. Eleplan keeps the whole care plan in one place.

Diagnoses, medications, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.